Transcatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve System: 30-Day Primary Endpoint Results From the REPRISE II Study

Study Questions:

What are the safety and performance profiles of transcatheter aortic valve replacement (TAVR) using the repositionable Lotus valve (Boston Scientific; Natick, MA) for severe, symptomatic, calcific aortic stenosis (AS)?